In the news release, SuperGen (Nasdaq: SUPG) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 10, 2008, issued on Monday, November 3 by SuperGen, Inc. over PR Newswire, we are advised by a representative of the company that SuperGen's presentation time has changed. The second paragraph, first sentence, should now read, "SuperGen's presentation at the Rodman & Renshaw 10th Annual Healthcare Conference is scheduled to begin at 12:00 p.m. EST (9:00 a.m. PST)" rather than, "11:35 a.m. EST (8:35 a.m. PST)" as originally issued inadvertently. The complete, corrected release follows: DUBLIN, Calif., Nov 3 /PRNewswire-FirstCall/ -- SuperGen, Inc. (NASDAQ: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008, at the New York Palace Hotel. SuperGen's presentation at the Rodman & Renshaw 10th Annual Healthcare Conference is scheduled to begin at 12:00 p.m. EST (9:00 a.m. PST). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at http://www.supergen.com/. The webcast will be archived for 90 days. About SuperGen Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com/. Contacts: SuperGen, Inc. Timothy L. Enns SVP, Corporate Communications & Business Development Tel: (925) 560-2810 Email: Dorland Global Public Relations Michael Beckerich (Media) Tel: (212) 677-7632 DATASOURCE: SuperGen, Inc. CONTACT: Timothy L. Enns, SVP of Corporate Communications & Business Development of SuperGen, Inc., +1-925-560-2810, , or Michael Beckerich of Dorland Global Public Relations, +1-212-677-7632, Web site: http://www.supergen.com/

Copyright